Compounds > cytarabine

cytarabine and salvin

cytarabine has been researched along with salvin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Harrison, JS; Studzinski, GP; Wang, X2
Danilenko, M; Harrison, JS; Nachliely, M; Studzinski, GP; Wang, X1
Danilenko, M; Dawod, A; Harrison, JS; Nachliely, M; Studzinski, GP; Wang, X1

Other Studies

4 other study(ies) available for cytarabine and salvin

ArticleYear
Enhancement of arabinocytosine (AraC) toxicity to AML cells by a differentiation agent combination.
    The Journal of steroid biochemistry and molecular biology, 2016, Volume: 164

    Topics: Abietanes; Annexin A5; Antimetabolites, Antineoplastic; Antioxidants; Apoptosis; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Differentiation; Comet Assay; Cytarabine; DNA Damage; Ergocalciferols; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Phosphorylation; Propidium; U937 Cells

2016
The role of VDR and BIM in potentiation of cytarabine-induced cell death in human AML blasts.
    Oncotarget, 2016, Jun-14, Volume: 7, Issue:24

    Topics: Abietanes; Adult; Aged; Aged, 80 and over; Apoptosis; Bcl-2-Like Protein 11; Cytarabine; Drug Synergism; Ergocalciferols; Female; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Receptors, Calcitriol; RNA Interference; Tumor Cells, Cultured; U937 Cells

2016
Participation of vitamin D-upregulated protein 1 (TXNIP)-ASK1-JNK1 signalosome in the enhancement of AML cell death by a post-cytotoxic differentiation regimen.
    The Journal of steroid biochemistry and molecular biology, 2019, Volume: 187

    Topics: Abietanes; Antineoplastic Agents; Antioxidants; Carrier Proteins; Cell Line, Tumor; Cell Survival; Cytarabine; Ergocalciferols; Humans; Leukemia, Myeloid, Acute; MAP Kinase Kinase Kinase 5; Mitogen-Activated Protein Kinase 8; Signal Transduction; Vitamins

2019
Differentiation agents increase the potential AraC therapy of AML by reactivating cell death pathways without enhancing ROS generation.
    Journal of cellular physiology, 2020, Volume: 235, Issue:1

    Topics: Abietanes; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Line, Tumor; Cytarabine; Ergocalciferols; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Reactive Oxygen Species; Receptors, Calcitriol; RNA Interference; RNA, Small Interfering; U937 Cells; Vitamin D

2020